Hezode, C; Almasio, PL; Bourgeois, S; Buggisch, P; Brown, A; Diago, M; Horsmans, Y; Szalay, Ferenc; Serfaty, L; Gaeta, GB; Planas, R; Schlag, M; Lonjon-Domanec, I; Omoruyi, E; DeMasi, R; Zeuzem, S
(2017)
BACKGROUND & AIMS: We investigated the efficacy and safety of simeprevir plus daclatasvir in treatment-naive patients with chronic, genotype 1b hepatitis C virus infection and advanced liver disease, excluding patients ...